AzTrials
AzTrials

Lumbar Spine FusionPhase 3NCT01986946

Epidural Analgesia Versus IV Analgesia in Lumbar Spine Fusions

A Phase 3 study testing Epidural Catheter - Dilaudid and Dilaudid in people with Lumbar Spine Fusion and Pain, run by Duke University at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

1. Protocol Title - A Comparison of Epidural Analgesia with Standard Care Following Lumbar Spinal Fusion: A Prospective Randomized Study 2. Purpose of the Study - This prospective randomized study will enroll 200 patients undergoing elective Lumbar Spinal Fusion at Duke University Hospital. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Lumbar Spine Fusion, Pain, Back Pain
What is being tested?
Epidural Catheter - Dilaudid and Dilaudid
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
17 participants
Where
1 siteUnited States
Study dates
Oct 2013to Sep 2015
Phase
Phase 3
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients who are scheduled for elective Transforaminal Lumbar Interbody Fusion surgery

Who cannot join

  • Baseline cognitive deficits sufficient to make objective pain self-assessments unreliable in the estimation of the Study Investigators.
  • Inability to follow directions or comprehend the English language.
  • Females who are pregnant as determined by positive pregnancy test on or before the day of surgery.
  • Prisoners.
  • Patient refusal to provide informed consent.
  • Allergy to amide local anesthetics (lidocaine, bupivacaine, ropivacaine).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke University Hospital

    Durham, North Carolina, 27710

Other trials in United States

About this study

Official title: A Comparison of Epidural Analgesia With Standard Care Following Lumbar Spinal Fusion: A Prospective Randomized Study

  1. Protocol Title - A Comparison of Epidural Analgesia with Standard Care Following Lumbar Spinal Fusion: A Prospective Randomized Study
  2. Purpose of the Study - This prospective randomized study will enroll 200 patients undergoing elective Lumbar Spinal Fusion at Duke University Hospital. The primary objective is to determine the effect of epidural analgesia, as compared with standard care, on post-operative analgesia.

Hypothesis:

The investigators hypothesize that patients undergoing Lumbar Spinal Fusion surgery with epidural catheter placement will have superior post-operative analgesia compared to patients undergoing standard care.

Being tested
Epidural Catheter - Dilaudid, Dilaudid
Medical subject headings
Pain, Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Epidural Catheter - DilaudidOther

    Placement of an epidural catheter to administer local anesthetic and opioid (dilaudid) to the epidural space will be studied as compared to use of intravenous opioid (dilaudid) for pain control following lumbar spine fusion surgery.

  • DilaudidDrug

    Patients in this arm will receive intravenous patient-controlled opioid analgesia (Dilaudid).

Study groups in NCT01986946
Study groupRoleWhat they receive
Intravenous opioidsExperimentalThis is the standard of care method for post-operative analgesia following lumbar spine fusion surgery. Participants randomly assigned to this arm will receive Intravenous Patient-Controlled Analgesia (IVPCA) with dilaudid (or other opioid) for post-operative pain control.
Receives: Drug: Dilaudid
Epidural CatheterExperimentalThe intervention to be tested in this study against standard intravenous opioids is infusion of local anesthetic and dilaudid via epidural catheter for post-operative pain control in patients undergoing lumbar spine fusion surgery.
Receives: Other: Epidural Catheter - Dilaudid

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post-operative Pain as Assessed by Visual Analogue Scale (VAS)

    The VAS scale ranges from 0 to 100 mm with the lower score indicating less pain and the higher score indicating greater pain.

    Measured: Postoperative day 1

Secondary outcomes (12)
  1. Patient Satisfaction With Perioperative Analgesia

    Patients will be assessed for satisfaction with their peri-operative analgesia in the recovery room and each day of their epidural infusion or intravenous opioid infusion by the Acute Pain Service, and at their surgical follow-up visit. Likert scale ranges from 1 to 5 (1=very satisfied and 5=Very Dissatisfied).

    Measured: Post-operative Day 1

  2. Patient Satisfaction With Perioperative Analgesia

    Patients will be assessed for satisfaction with their peri-operative analgesia in the recovery room and each day of their epidural infusion or intravenous opioid infusion by the Acute Pain Service, and at their surgical follow-up visit. Likert scale ranges from 1 to 5 (1=very satisfied and 5=Very Dissatisfied).

    Measured: 6-Week Follow up Visit

  3. Patient Satisfaction With Overall Care

    Likert scale ranges from 1 to 5 (1=very satisfied and 5=Very Dissatisfied).

    Measured: 6-Week Follow up Visit

  4. Number of Participants With Events of Special Interest

    Patients will be assessed for development of a deep vein thrombosis after surgery, and surgical site infection.

    Measured: Post-operative Day 30

  5. Number of Participants With Adverse Events Related to the Study

    Patients will be assessed in the recovery room and each day of their epidural or intravenous opioid infusions, and at their surgical follow-up visit.

    Measured: 6-week Follow up Visit

  6. Total Post-operative Opioid Consumption

    Measured: during hospitalization (approximately 3-8 days)

  7. Number of Participants Experiencing Delirium

    Measured: Post-operative Day 1

  8. Number of Participants Experiencing Delirium

    Measured: Post-operative Day 2

  9. Number of Participants Experiencing Delirium

    Measured: Post-operative Day 3

  10. Number of Participants Readmitted to Hospital Within 30 Days of Surgery

    Measured: Post-operative Day 30

  11. Length of Hospital Stay

    Measured: during hospitalization (approximately 3-8 days)

  12. Wound Infection Rates

    Measured: during hospitalization (approximately 3-8 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2013 (estimated)
  2. Study startOct 2013
  3. Primary completionSep 2015
  4. Study completionSep 2015

Why it stopped: Lack of recruitment.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
17 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01986946
Sponsor's protocol ID
Pro00041252
Status last verified
Jan 2017
First submitted
3 Jan 2013
Last updated
23 Feb 2017
Data monitoring committee
No

Publications

  • Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA Jr, Wu CL. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA. 2003 Nov 12;290(18):2455-63. doi: 10.1001/jama.290.18.2455.

    PubMed 14612482
  • Abrishamkar S, Eshraghi N, Feizi A, Talakoub R, Rafiei A, Rahmani P. Analgesic effects of ketamine infusion on postoperative pain after fusion and instrumentation of the lumbar spine: a prospective randomized clinical trial. Med Arh. 2012;66(2):107-10. doi: 10.5455/medarh.2012.66.107-110.

    PubMed 22486142
  • Sekar C, Rajasekaran S, Kannan R, Reddy S, Shetty TA, Pithwa YK. Preemptive analgesia for postoperative pain relief in lumbosacral spine surgeries: a randomized controlled trial. Spine J. 2004 May-Jun;4(3):261-4. doi: 10.1016/j.spinee.2003.11.009.

    PubMed 15125846
  • Cohen BE, Hartman MB, Wade JT, Miller JS, Gilbert R, Chapman TM. Postoperative pain control after lumbar spine fusion. Patient-controlled analgesia versus continuous epidural analgesia. Spine (Phila Pa 1976). 1997 Aug 15;22(16):1892-6; discussion 1896-7. doi: 10.1097/00007632-199708150-00016.

    PubMed 9280026
  • Sucato DJ, Duey-Holtz A, Elerson E, Safavi F. Postoperative analgesia following surgical correction for adolescent idiopathic scoliosis: a comparison of continuous epidural analgesia and patient-controlled analgesia. Spine (Phila Pa 1976). 2005 Jan 15;30(2):211-7. doi: 10.1097/01.brs.0000150832.53604.64.

    PubMed 15644759
  • Yukawa Y, Kato F, Ito K, Terashima T, Horie Y. A prospective randomized study of preemptive analgesia for postoperative pain in the patients undergoing posterior lumbar interbody fusion: continuous subcutaneous morphine, continuous epidural morphine, and diclofenac sodium. Spine (Phila Pa 1976). 2005 Nov 1;30(21):2357-61. doi: 10.1097/01.brs.0000184377.31427.fa.

    PubMed 16261108
  • Parker SL, Lerner J, McGirt MJ. Effect of minimally invasive technique on return to work and narcotic use following transforaminal lumbar inter-body fusion: a review. Prof Case Manag. 2012 Sep-Oct;17(5):229-35. doi: 10.1097/NCM.0b013e3182529c05.

    PubMed 22850657

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Epidural Catheter - Dilaudid and Dilaudid in people with Lumbar Spine Fusion and Pain, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 23 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 11 Nov 2016). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post-operative Pain as Assessed by Visual Analogue Scale (VAS) (time frame: Postoperative day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01986946, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in